![Nat Ricciardi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nat Ricciardi
Direktor/Vorstandsmitglied bei RAPID MICRO BIOSYSTEMS, INC.
Vermögen: 2 Mio $ am 31.05.2024
Profil
Mr. Natale S.
Ricciardi is an Independent Director at Prestige Consumer Healthcare, Inc., an Independent Director at Rapid Micro Biosystems, Inc., an advisor and Board Member at Healthcare Royalty Management LLC and a Member at The City College 21st Century Foundation, Inc. He is on the Board of Directors at Prestige Consumer Healthcare, Inc., Rapid Micro Biosystems, Inc. and Healthcare Royalty Management LLC.
Mr. Ricciardi was previously employed as an Independent Director by Asterias Biotherapeutics, Inc., an Independent Director by Dynavax Technologies Corp., a President by Pfizer Global Manufacturing, a Senior Vice President by Pfizer Inc., and a Vice President-Manufacturing by Pfizer Animal Health (New Jersey).
He also served on the board at Mediacom Communications Corp., National Association of Manufacturers and Nuron Biotech, Inc. He received his undergraduate degree from City University of New York and an MBA from Fordham University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
01.08.2023 | 27 098 ( 0,05% ) | 2 Mio $ | 31.05.2024 | |
23.05.2024 | 14 300 ( 0,04% ) | 11 440 $ | 31.05.2024 |
Aktive Positionen von Nat Ricciardi
Unternehmen | Position | Beginn |
---|---|---|
RAPID MICRO BIOSYSTEMS, INC. | Direktor/Vorstandsmitglied | 15.03.2016 |
PRESTIGE CONSUMER HEALTHCARE INC. | Direktor/Vorstandsmitglied | 26.05.2016 |
The City College 21st Century Foundation, Inc. | Corporate Officer/Principal | - |
Healthcare Royalty Management LLC
![]() Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Direktor/Vorstandsmitglied | 01.01.2013 |
Ehemalige bekannte Positionen von Nat Ricciardi
Unternehmen | Position | Ende |
---|---|---|
ASTERIAS BIOTHERAPEUTICS INC | Direktor/Vorstandsmitglied | 08.03.2019 |
Mediacom Communications Corp.
![]() Mediacom Communications Corp. Cable/Satellite TVConsumer Services Mediacom Communications Corp. provides cable and Internet access services. Its products include Xtream, television, internet, phone, and home security. The company was founded by Rocco B. Commisso in 1995 and is headquartered in Chester, NY. | Direktor/Vorstandsmitglied | 01.01.2011 |
PFIZER, INC. | Private Equity Investor | 01.01.2011 |
Pfizer Global Manufacturing | Präsident | 01.01.2011 |
ZOETIS INC. | Corporate Officer/Principal | 01.01.1999 |
Ausbildung von Nat Ricciardi
City University of New York | Undergraduate Degree |
Fordham University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
PFIZER, INC. | Health Technology |
DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
PRESTIGE CONSUMER HEALTHCARE INC. | Health Technology |
RAPID MICRO BIOSYSTEMS, INC. | Producer Manufacturing |
ZOETIS INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
Mediacom Communications Corp.
![]() Mediacom Communications Corp. Cable/Satellite TVConsumer Services Mediacom Communications Corp. provides cable and Internet access services. Its products include Xtream, television, internet, phone, and home security. The company was founded by Rocco B. Commisso in 1995 and is headquartered in Chester, NY. | Consumer Services |
Asterias Biotherapeutics, Inc.
![]() Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
National Association of Manufacturers
![]() National Association of Manufacturers Miscellaneous Commercial ServicesCommercial Services The National Association of Manufacturers is an organization that works for the success of over 12.9 million people who are involved in manufacturing. The non-profit company is based in Washington and has subsidiaries in the United States. The American company's work is based on four core values that drive the industry. The company commissioned a study in August 2015, which found that the EPA's proposed ozone rule could reduce GDP by $140 billion. The CEO of the company is Jay Timmons. | Commercial Services |
Healthcare Royalty Management LLC
![]() Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Finance |
The City College 21st Century Foundation, Inc. | |
Nuron Biotech, Inc.
![]() Nuron Biotech, Inc. BiotechnologyHealth Technology Nuron Biotech, Inc. markets and develops vaccines for the prevention and treatment of infectious diseases. It develops novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. The firm is advancing products to meet unmet medical needs in the areas of multiple sclerosis, alzheimer's, hepatitis b and hepatitis c for patients across the globe. The company was founded by Vithalbhai Dhaduk, Shankar Musunuri and David Zeng in 2009 and is headquartered in Exton, PA. | Health Technology |
Pfizer Global Manufacturing |